Stabilized Vitamin C Improves Brain Aging in Mice

The mice performed better on memory tests.


Vitamin C FruitsVitamin C Fruits

Korean scientists publishing in Nature were able to increase the stability of vitamin C, a powerful antioxidant, using a short, engineered DNA molecule called an aptamer. The result improved various aspects of brain aging in naturally aged mice [1].

The unstable antioxidant

Oxidative stress is one of the most harmful age-related processes. In particular, it damages the cardiovascular system, including microvasculature in the brain, leading to increased neuroinflammation and age-related neurodegeneration [2].

Vitamin C is a powerful antioxidant, but itโ€™s relatively unstable, being quickly degraded in the body. Aptamers are short single-stranded molecules of DNA or RNA that bind to a specific target, including small molecules. The aptamer that this paper’s authors developed, Aptaminยฎ C320, forms a complex with vitamin C, preventing its oxidation.

Improved cognitive function

The resulting aptamer-vitamin complex, NXP032, was given to aged mice for 8 weeks. At the end of the treatment, the researchers conducted two cognitive tests. In the passive avoidance test, mice with better memory and cognition are expected to spend more time (latency) before entering a part of the enclosure associated with previous negative experiences. In the Y maze test, cognitively normal rodents should prefer an unexplored maze arm to the one they have recently visited (alternation).

In both tests, old mice showed significant cognitive impairment compared to young controls. Both vitamin C and the aptamer alone produced some improvement (the latter probably by binding and enhancing vitamin C that was already present in the body), but unsurprisingly, NPX032 outperformed them, resulting in significant improvement almost to the level of young controls.

Vitamin C Mice

Better BBB, less microglia activation

This treatment was also found to protect the tiny blood vessels throughout the brain: its microvasculature. Levels of the protein PECAM-1, which is expressed by endothelial cells in blood vessels in the brain, were significantly higher in the study group compared to old controls, while fragmentation of brain microvasculature was significantly lower.

The brain is an extremely vulnerable organ that is isolated from the rest of the body by the blood-brain barrier (BBB), which prevents pathogens from entering the precious brain tissue. The expression of several BBB-associated proteins, impaired in aged mice, was significantly restored by the treatment.

Microglia, the brain’s resident immune cells, tend to become overactivated with age, which drives neuroinflammation. The treatment decreased the expression of two microglia-associated proteins to levels comparable with young controls.

Decreased blood flow and increased occlusion, two hallmarks of cardiovascular aging, contribute to the appearance of very thin blood vessels that are devoid of endothelial cells. According to the researchers, the prevalence of these “string vessels” was much higher in aged controls compared to younger mice but was partially rescued by the treatment.

The functional capacity of the brain gradually decreases during aging, resulting in decrements in learning and memory, attention, decision-making speed, sensory perception, and motor coordination. These aspects of cognitive decline are among the biggest health threats in old age and are manifested by a loss of brain function. Many animal experiments have reported that aged rodents have decreased learning and memory ability in the Morris water maze and elevated plus maze tests compared to young rodents. Consistent with previous studies, our study found that 20-month-old mice had impairments in spatial learning and memory, but the NXP032 group showed an increased spontaneous rate in the Y-maze test and a significant increase in the passive avoidance test. Based on these results, we confirmed that NXP032 can improve cognitive impairment due to aging.

Aptamersโ€™ potential

Aptamers have numerous potential uses in medicine due to their ability to effectively and selectively bind to a wide range of targets, from small molecules to proteins. Many are currently being developed, and some have already been approved by the FDA, such as the aptamer pegaptanib [3], which is used against ocular vascular diseases. While NXP032 has not been approved for any indication yet, the FDA has recently granted it Generally Recognized as Safe (GRAS) status.

This particular study, as the researchers admit, had its share of limitations. First, in the aged mice groups, only female animals were used. This might have affected its comparison to the young control group, which was sexually heterogenous, since we know that male and female mammals can react differently to anti-aging therapies. Second, vascular damage and BBB integrity were measured via indirect markers. However, the idea of increasing stability of anti-aging compounds via aptamer binding has a lot of potential.

We would like to ask you a small favor. We are a non-profit foundation, and unlike some other organizations, we have no shareholders and no products to sell you. We are committed to responsible journalism, free from commercial or political influence, that allows you to make informed decisions about your future health.

All our news and educational content is free for everyone to read, but it does mean that we rely on the help of people like you. Every contribution, no matter if itโ€™s big or small, supports independent journalism and sustains our future. You can support us by making a donation or in other ways at no cost to you.

Developing a Treatment for Arthritis from Stem Cell Signals

Resarchers publishing in Aging have found that extracellular vesicles (EVs) derived from human umbilical cord mesenchymal stem cells (MSCs) reduce...

Creating a Noise Clock to Measure Biological Age

Publishing in Aging, the Conboy research lab has outlined the problems with existing machine learning-based clocks and created a new...

EARD2023: Using NFTs to Support Video Gaming for Good

In this talk, Lifespan.io President Keith Comito describes use cases for "Proof of Philanthropy" (PoP) dynamic NFTs - a new...

Senolytics as a Potential Back Pain Treatment

In a recent paper, researchers from McGill University in Canada have investigated how a combination of two senolytics, RG-7112 and...


[1] Lee, J. M., Lee, J. H., Kim, S. H., Sim, T. H., & Kim, Y. J. (2023). NXP032 ameliorates cognitive impairment by alleviating the neurovascular aging process in aged mouse brain. Scientific Reports, 13(1), 8594.

[2] Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., … & Abete, P. (2018). Oxidative stress, aging, and diseases. Clinical interventions in aging, 757-772.

[3] Ng, E. W., Shima, D. T., Calias, P., Cunningham Jr, E. T., Guyer, D. R., & Adamis, A. P. (2006). Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nature reviews drug discovery, 5(2), 123-132.

About the author
Arkadi Mazin

Arkadi Mazin

Arkadi is a seasoned journalist and op-ed author with a passion for learning and exploration. His interests span from politics to science and philosophy. Having studied economics and international relations, he is particularly interested in the social aspects of longevity and life extension. He strongly believes that life extension is an achievable and noble goal that has yet to take its rightful place on the very top of our civilizationโ€™s agenda โ€“ a situation he is eager to change.
No Comments
Write a comment:


Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.